WallStreetZenWallStreetZen

NYSEMKT: CATX
Perspective Therapeutics Inc Stock Ownership - Who owns Perspective Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Perspective Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert F. Williamson IiiDirector2025-03-3138,145$2.14
$81.78kBuy
Lori A. WoodsDirector2025-03-3123,475$2.13
$50.00kBuy
Juan GrahamChief Financial Officer2025-03-2833,333$2.25
$74.93kBuy
Johan M. SpoorChief Executive Officer2025-03-2822,026$2.24
$49.38kBuy
Johan M. SpoorChief Executive Officer2025-03-284,650$2.21
$10.29kBuy
Robert F. Williamson IiiDirector2025-03-2822,192$2.27
$50.38kBuy
Johan M. SpoorCEO2024-12-048,000$3.77
$30.14kBuy
Heidi HensonDirector2024-12-0425,975$3.85
$100.00kBuy
Johan M. SpoorCEO2024-11-2514,500$3.78
$54.87kBuy
Jonathan Robert HuntChief Financial Officer2024-11-2510,000$3.88
$38.80kBuy

1 of 2

CATX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CATX insiders and whales buy or sell their stock.

CATX Shareholders

What type of owners hold Perspective Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lantheus Alpha Therapy LLC157.24%116,773,394$429.73MInsider
Fmr LLC14.95%11,102,770$40.86MInstitution
Blackrock Inc5.78%4,294,151$15.80MInstitution
Vanguard Group Inc4.41%3,274,333$12.05MInstitution
Millennium Management LLC3.49%2,593,599$9.54MInstitution
Nuveen LLC3.09%2,297,314$8.45MInstitution
Avidity Partners Management LP2.50%1,858,596$6.84MInstitution
Morgan Stanley2.19%1,623,388$5.97MInstitution
Nicholson Wealth Management Group LLC2.17%1,614,283$5.94MInstitution
Geode Capital Management LLC1.86%1,382,814$5.09MInstitution

1 of 3

CATX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CATX25.94%74.06%Net Buying
NNOX19.63%0.00%
TLSI17.23%41.95%Net Buying
CERS76.23%7.25%Net SellingNet Buying
OM70.37%29.63%Net SellingNet Selling
View Top Medical Device Stocks

Perspective Therapeutics Stock Ownership FAQ

Who owns Perspective Therapeutics?

Perspective Therapeutics (NYSEMKT: CATX) is owned by 57.21% institutional shareholders, 163.35% Perspective Therapeutics insiders, and 0.00% retail investors. Lantheus Alpha Therapy LLC is the largest individual Perspective Therapeutics shareholder, owning 116.77M shares representing 157.24% of the company. Lantheus Alpha Therapy LLC's Perspective Therapeutics shares are currently valued at $404.04M.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.